No description available.

Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2018-08-09T11:39:12Z No. of bitstreams: 2 Dissertaçao - Lara Marques Naves - 2018.pdf: 4245553 bytes, checksum: 32754e93d07b1f96bc7f0b9a2bc618ff (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2018-08-09T12:20:22Z (GMT) No. of bitstreams: 2 Dissertaçao - Lara Marques Naves - 2018.pdf: 4245553 bytes, checksum: 32754e93d07b1f96bc7f0b9a2bc618ff (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Made available in DSpace on 2018-08-09T12:20:22Z (GMT). No. of bitstreams: 2 Dissertaçao - Lara Marques Naves - 2018.pdf: 4245553 bytes, checksum: 32754e93d07b1f96bc7f0b9a2bc618ff (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2018-03-02 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / Hemodynamic and cardiovascular benefits from the hypertonic saline solution (HS) use in the hypotensive hemorrhage (HH) treatment have been reported for several years. Recent investigations have shown the participation of central nervous system (CNS) regions, such as A1 neuronal clusters (located in the caudal ventrolateral medulla; CVLM), A2 neuronal clusters (located in the nucleus of the solitary tract; NTS) and the Median Preoptic Nucleus (MnPO) on hemodynamic responses induced by sodium chloride overload in normovolemic animals. However, the role of the above structures in cardiovascular recovery and autonomic changes induced by HS solution administration in animals submitted to HH has not yet been evaluated. Thus, the present study evaluated the A1, A2 neuronal clusters and MnPO nucleus involvement in the cardiovascular and autonomic responses promoted by HS solution infusion in hypovolemic animals. For this, wistar rats (280-320 g) were separated into four protocols: I. A2 neuronal cluster lesion (A2 Sham: n = 6; A2 Experimental: n = 6); II. A1 neuronal cluster lesion (A1 Sham: n = 6; A1 Experimental: n = 6); III. A1 and A2 neural clusters concomitant lesions (A1 + A2 Sham: n = 6; A1 + A2 Experimental: n = 6) and IV. Pharmacological inhibition of MnPO (MnPO Sham: n = 6; MnPO Experimental: n = 6). The animals of the first three protocols were anesthetized and subjected to saporin-anti-DβH nanoinjections for neuronal lesion (100 nL, 0.105 ng/nl) in experimental groups and Saporin nanoinjections (100 nL, 0.022 ng/nL) in sham groups for fictitious neuronal lesion, respectively, in the NTS, CVLM or simultaneously in the NTS and CVLM regions. After 20 days of recovery, the animals were anesthetized and instrumented to mean arterial pressure (MAP), heart rate (HR) and renal sympathetic nervous activity (RSNA) recordings. Then, HH was performed by blood withdrawal until MAP reached approximately 60 mmHg. After 20 min of HH, sodium overload (3M NaCl, 1.8 mL/g, 90 seconds of infusion, i.v) was conducted. In another series of experiments, MnPO Sham and MnPO Experimental groups were anesthetized and instrumented for MAP, HR and RSNA recordings. Then, the animals were submitted to HH and HS infusion at the end of the hemorrhage. GABAergic agonist Muscimol (4 mM, 100 nL, MnPO Experimental group) or saline nanoinjections (0.15 M, 100 nL, MnPO Sham group) were performed in the MnPO after 10 min from the start of HH. HH-induced hypotension, bradycardia and renal sympathoinhibition in the animals of the A2 Sham, A1 Sham, A1 + A2 Sham and MnPO Sham groups. In the sham groups, HS infusion after HH reestablished MAP, HR, and did not alter the renal sympathoinhibition generated during hypovolemia. In the A2 Experimental and A1 Experimental groups, the specific lesion of A1 or A2 neurons did not alter the hypotension, bradycardia and renal sympathoinhibition caused during HH. In addition, the A1 or A2 neurons specific lesion did not alter the reestablishment of MAP, HR and the RSNA reduction after HS solution infusion. However, in the animals of the A1 + A2 experimental group, the simultaneous A1 and A2 neurons lesion did not alter the decrease in MAP and HR observed during HH, but abolished renal sympathoinhibition. In addition, simultaneous A1 and A2 neurons lesion abolished MAP restoration and ANSR reduction after HS infusion, while HR restoration was not modified. In the MnPO experimental animals, MnPO nucleus inhibition did not alter the decrease in MAP and HR observed during HH, but abolished renal sympathoinhibition. However, MnPO inhibition abolished the MAP restoration and promoted strong sympathetic activation in the renal bed after HS infusion, while HR restoration was not modified. These results suggest that the A1, A2 neuronal clusters and MnPO nucleus are part of the integration and transmission information circuits about changes in plasma osmolarity, participating in cardiovascular and autonomic recovery induced by sodium chloride overload in animals submitted to HH. / Os benefícios hemodinâmicos e cardiovasculares provenientes do uso de solução salina hipertônica (SH) no tratamento da hemorragia hipotensiva (HH) são relatados há vários anos. Recentes investigações mostraram a participação de regiões do sistema nervoso central (SNC), como os grupamentos neuronais A1 (localizado na região caudoventrolateral do bulbo; CVLM), A2 (localizado no núcleo do tracto solitário; NTS) e do núcleo Pré-óptico mediano (MnPO) nas respostas hemodinâmicas induzidas pela sobrecarga de cloreto de sódio em animais normovolêmicos. Entretanto, o papel das estruturas acima relacionadas na recuperação cardiovascular e nas alterações autonômicas induzidas pela administração de solução SH em animais submetidos à HH ainda não foi avaliado. Assim, o presente estudo buscou avaliar o envolvimento dos grupamentos neuronais A1, A2 e do núcleo MnPO nas respostas cardiovasculares e autonômicas promovidas pela infusão de solução SH em animais hipovolêmicos. Para isto, ratos Wistar (280-320 g) foram separados em quatro protocolos: I. Lesão do grupamento neuronal A2 (Controle A2: n=6; Experimental A2: n=6); II. Lesão do grupamento neuronal A1 (Controle A1: n=6; Experimental A1: n=6); III. Lesões concomitantes dos grupamentos neuronais A1 e A2 (Controle A1 + A2: n=6; Experimental A1 + A2: n=6) e IV. Inibição farmacológica do núcleo MnPO (Controle MnPO: n=6; Experimental MnPO: n=6). Os animais dos três primeiros protocolos foram anestesiados e submetidos a nanoinjeções de saporina-anti-DβH para lesão neuronal (100 nL, 0,105 ng/nL) nos grupos experimentais e Saporina (100 nL, 0,022 ng/nL) nos grupos controles para lesão neuronal fictícia, respectivamente, no NTS, na região CVLM ou conjuntamente no NTS e CVLM. Após 20 dias de recuperação, os animais foram novamente anestesiados e instrumentalizados para registro da pressão arterial média (PAM), frequência cardíaca (FC) e atividade nervosa simpática renal (ANSR). Em seguida, a HH foi realizada através da retirada de sangue até que a PAM atingisse aproximadamente 60 mmHg. Após 20 min de HH foi conduzida a sobrecarga de sódio (NaCl 3M, 1,8 mL/kg, 90 segundos de infusão, i.v). Em outra série de experimentos, os animais dos grupos controle MnPO e Experimental MnPO foram anestesiados e instrumentalizados para registro da PAM, FC, ANSR. Em seguida, foram submetidos à HH e a infusão de solução SH ao final da hemorragia. Nanoinjeções do agonista GABAérgico, muscimol (4 mM, 100 nL, grupo experimental MnPO) ou salina (0,15 M; 100 nL; grupo controle MnPO) foram realizadas no MnPO após 10 min do início da HH. A HH promoveu hipotensão, bradicardia e simpatoinibição no território renal nos animais dos grupos controle A2, controle A1, controle A1 + A2 e controle MnPO. Nos grupos controle, a infusão de solução SH após a HH reestabeleceu a PAM, FC e não alterou a simpatoinibição renal gerada durante a hipovolemia. Nos animais dos grupos experimental A2 e experimental A1, a lesão especifica dos neurônios A1 ou A2 não alterou a hipotensão, bradicardia e simpatoinibição provocados durante a HH. Em adição, a lesão especifica dos neurônios A1 ou A2 não alterou o reestabelecimento da PAM, FC e a queda da ANSR gerada após a infusão de solução SH. Entretanto, nos animais do grupo experimental A1 + A2, a lesão simultânea dos neurônios A1 e A2 não alterou a queda da PAM, da FC observada durante a HH, mas aboliu a simpatoinibição renal. Ademais, a lesão simultânea dos neurônios A1 e A2 aboliu a restauração da PAM e a redução da ANSR após a infusão de solução SH, enquanto a restauração da FC não foi modificada. Nos animais do grupo experimental MnPO, a inibição do MnPO não alterou a queda da PAM e da FC observadas durante a HH, entretanto aboliu a simpatoinibição renal. Porém, a inibição do núcleo MnPO aboliu a restauração da PAM e promoveu forte simpatoexcitação no leito renal após a infusão de solução SH, enquanto a restauração da FC não foi modificada. Esses resultados sugerem que os neurônios dos grupamentos A1, A2 e o núcleo MnPO fazem parte dos circuitos de integração e transmissão de informações a respeito de mudanças na osmolaridade plasmática, participando da recuperação cardiovascular e autonômica induzida pela sobrecarga de cloreto de sódio em animais submetidos à HH.

Le récepteur du facteur de libération de l’hormone de croissance (GHRHR) est un récepteur de la famille des récepteurs couplés aux protéines G. Il est fortement exprimé dans les cellules somatotropes de l’hypophyse antérieure de plusieurs mammifères. Ce récepteur exerce un rôle primordial dans la stimulation de la synthèse et de la sécrétion de l’hormone de croissance ainsi que dans la prolifération des somatotropes. Au niveau extrahypophysaire, les niveaux les plus élevés d’ARNm du GHRHR se retrouvent dans le rein. Toutefois, aucune analyse immunohistochimique n’existe encore sur la localisation précise et la quantification sur les niveaux de GHRHR dans les différents segments du rein de rat et sa dynamique d’expression en situation normale et pathologique telle que l’ischémie. De plus, dans le rein humain normal, aucune information n’est présentement disponible. Le premier article de ce mémoire a pour objectif d’identifier, par immunofluorescence directe, la localisation du GHRHR à travers le système tubulaire rénal, chez le rat jeune en bonne santé. Nos résultats mettent en évidence que dans le rein de rat sain, le GHRHR est exprimé dans les cellules du tubule proximal contourné et droit, de l’anse de Henlé ascendante épaisse corticale et médullaire et de l’anse de Henlé ascendante mince. Le cortex et la bande externe de la médulla externe seraient les deux régions où l’expression est la plus élevée. À la suite d’une insulte rénale comme l’ischémie-reperfusion (IR) chaude, nos résultats démontrent que l’expression du GHRHR est régulée à la baisse dans ces mêmes régions. De plus, une augmentation de certains marqueurs de détérioration cellulaire est présente comme l’enzyme initiatrice, la caspase-9 clivée et effectrice (caspase-3 clivée), des fragments d’ADN et la surexpression d’indication d’injure tissulaire comme la protéine Kidney Injury Molecule 1 (KIM-1). L’ensemble de ces résultats ouvre plusieurs pistes d’études concernant l’importance du GHRHR en rénoprotection. Le deuxième article de ce mémoire a pour objectif d’identifier, par immunofluorescence directe, la localisation du GHRHR à travers le système tubulaire rénal humain. Nos résultats suggèrent que dans le rein humain sain, le GHRHR est davantage exprimé dans le cortex, plus précisément, au niveau du tubule proximal droit et contourné et l’anse de Henlé corticale ascendante épaisse. L’expression du GHRHR est aussi notable au niveau de la région médullaire, pour être plus spécifique, au niveau de l’anse de Henlé médullaire ascendante épaisse et de la médulla. Ainsi, comme chez le rat, l’expression du GHRHR rénal est régio-spécifique. Finalement, le troisième article de ce mémoire est une revue de la littérature ayant pour but d’établir un lien entre les mécanismes connus du stress oxydant dans un contexte d’IR rénale et son impact spécifique dans la médulla. Cet article met en évidence que les différents segments du rein réagissent différemment à une agression oxydante et que la médulla est la région la plus vulnérable. De plus, cette revue de la littérature souligne que les différents types de mécanismes connus du stress oxydant dans un contexte d’IR rénale, tel que la production de dérivés réactifs de l’oxygène, ciblent principalement deux structures du néphron : le tubule proximal et l’anse de Henlé ascendante épaisse médullaire. Les principales répercussions de ces mécanismes observables sont l’inflammation, l’apoptose cellulaire et la diminution des fonctions rénales. Ces mécanismes peuvent aussi être utilisés comme un outil de diagnostic ou de détermination de la santé de l’organe. / The growth hormone-releasing factor receptor (GHRHR) is a receptor of the family of G- protein-coupled receptors. It is highly expressed in the somatotropic cells of the anterior pituitary of several mammals. This receptor plays an essential role in the stimulation of the synthesis and secretion of growth hormone as well as in the proliferation of somatotrophs. At the extra- pituitary level, the highest levels of GHRHR mRNA are found in the kidney. However, no immunohistochemical analysis yet exists on precise localization and quantification of GHRHR levels in the different segments of the rat kidney and its expression dynamics in normal and pathological situations such as ischemia. Additionally, in the normal human kidney, no information is currently available. The first article of this thesis aims to identify, by direct immunofluorescence, the localization of the GHRHR through the renal tubular system, in young healthy rats. Our results show that in the healthy rat kidney, GHRHR is expressed in the cells of the convoluted and right proximal tubule, of the cortical and medullary thick ascending loop of Henle and of the thin ascending loop of Henle. The cortex and the outer band of the outer medulla would be the two regions where the expression is the highest. Following a renal insult such as warm ischemia-reperfusion (RI), our results demonstrate that GHRHR expression is down-regulated in these same regions. In addition, an increase in certain markers of cellular damage is present including initiating enzymes, cleaved and effector caspase-9 (cleaved caspase-3), DNA fragments and overexpression indicative of tissue injury such as protein Kidney Injury Molecule 1 (KIM-1). All these results open up several avenues of study concerning the importance of GHRHR in renoprotection. The second article of this thesis aims to identify, by direct immunofluorescence, the localization of the GHRHR through the human renal tubular system. Our results suggest that in the healthy human kidney, the GHRHR is more expressed in the cortex, more precisely at the level of the right, convoluted proximal tubule and the thick ascending cortical loop of Henle. The expression of GHRHR is also appreciable at the level of the medullary region, more precisely at the level of the thick ascending medullary loop of Henle, and the medulla. Thus, as in rats, the expression of renal GHRHR is region specific. Finally, the third article of this thesis is a review of the literature aimed at establishing a link between the known mechanisms of oxidative stress in the context of renal IR and its specific impact in the medulla. This article highlights that the different segments of the kidney react differently to an oxidative attack and that the medulla is the most vulnerable region. In addition, this review of the literature underlines that the different types of known mechanisms of oxidative stress in a context of renal IR, such as the production of reactive oxygen species, mainly target two structures of the nephron: the proximal tubule and the thick ascending loop of Henle. The main repercussions of these observable mechanisms are inflammation, cellular apoptosis and reduced renal function. These mechanisms can also be used as a diagnostic tool or to determine the health of the organ.

Recent research demonstrated that besides a role in sex determination and male fertility, the Y chromosome is involved in additional functions including prostate cancer, sex-specific effects on the brain and behaviour, graft-versus-host disease, nociception, aggression and autoimmune diseases. The results presented in this thesis include an analysis of sex-biased genes encoded on the X and Y chromosomes of rodents. Expression data from six different somatic tissues was analyzed and we found that the X chromosome is enriched in female biased genes and depleted of male biased ones. The second study described copy number variation (CNV) patterns in a world-wide collection of human Y chromosome samples. Contrary to expectations, duplications and not deletions were the most frequent variations. We also discovered novel CNV patterns of which some were significantly overrepresented in specific haplogroups. A substantial part of the thesis focuses on analysis of spatial expression of two Y-encoded brain-specific genes, namely PCDH11Y and NLGN4Y. The perhaps most surprising discovery was the observation that X and Y transcripts of both gene pairs are mostly expressed in different cells in human spinal cord and medulla oblongata. Also, we detected spatial expression differences for the PCDH11X gene in spinal cord. The main focus of the spatial investigations was to uncover genetically coded sexual differences in expression during early development of human central nervous system (CNS). Also, investigations of the expression profiles for 13 X and Y homolog gene pairs in human CNS, adult brain, testes and still-born chimpanzee brain samples were included. Contrary to previous studies, we found only three X-encoded genes from the 13 X/Y homologous gene pairs studied that exhibit female-bias. We also describe six novel non-coding RNAs encoded in the human MSY, some of which are polyadenylated and with conserved expression in chimpanzee brain. The description of dimorphic cellular expression patterns of X- and Y-linked genes should boost the interest in the human specific gene PCDH11Y, and draw attention to other Y-encoded genes expressed in the brain during development. This may help to elucidate the role of the Y chromosome in sex differences during early CNS development in humans. / <p>chinese, finnish, norwegian, schizophrenia, bipolar, bipolar disorder, msy, male specific region Y, PAR1, PAR2, pseudoautosomal, male-biased, female-biased, male biased, female biased, ashkenazi population, structure, variants, YHRD, Elena Jazin, Björn Reinius, Per Ahlberg, brain, hjärna, CNS, central nervous system, IR2, inverted repeat 2, isodicentric, genetics, genetik, padlock, rolling circle, amplification, PCR, sY1191, sY1291, STS, DDX3Y, DAZ, AZFa, AZFb, AZFc, AZF, Repping, haplogroup J, rearrangements, DE-M145, I-M170, E-M96, Q-M242, R-M207, O-M175, G-M201, D-M174, C-M130, NO-M214, N-M231, poland</p>